main difference between semaglutide and tirzepatide vs Tirzepatide vs. Semaglutide for Weight

It is not approved for weight loss

MACE, major adverse cardiovascular events

#MASH #Hepatology #MetabolicHealth #GLP1 To view or add a comment, sign in Narrative review proposes pancreatic exocrine fibrosis and profibrotic signalling as key drivers of type 3c diabetes, with a potential role in type 2 and type 1 diabetes, and summarises unanswered questions & suggests potential novel therapeutic targets To view or add a comment, sign in We are very grateful to Diabetologia for inviting us to review the growing evidence supporting a profibrotic signalling cycle involving stellate cells, macrophages and islet endocrine cells themselves in the pathogenesis of pancreatogenic diabetes including diabetes associated with pancreatic cancer

Retatrutide is not commercially available